Strategies to Manage Antibody Drug Conjugates (ADC) - Related Toxicities in Breast Cancer - Episode 13
Key Takeaways and Clinical Practice Pearls in the Treatment of Patients with Breast Cancer Receiving ADCs
Panelists discuss how addressing unmet needs in patient selection, resistance mechanisms, and long-term outcomes can enhance the efficacy of antibody-drug conjugates in breast cancer treatment.
Video content above is prompted by the following:
Can you share some of the biggest unmet need(s) or treatment gaps that still exist for patients with breast cancer who are receiving antibody-drug conjugates and some practice pearls you wish to share with your community colleagues?
Related Content:
